HF
AMAG

HRT Financial’s AMAG Pharmaceuticals AMAG Stock Holding History

HRT Financial’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-42,417
Closed -$398K – 2805
2020
Q3 		$398K Buy
42,417
+30,337
+251% +$288K 0.01% 990
2020
Q2 		$92K Buy
+12,080
New +$92.4K ﹤0.01% 1258
2020
Q1 		– Sell
-18,000
Closed -$219K – 1557
2019
Q4 		$219K Buy
18,000
+4,712
+35% +$51.5K 0.01% 899
2019
Q3 		$153K Buy
+13,288
New +$140K 0.01% 1197

HRT Financial's AMAG Position: Q4 2020 in Review

HRT Financial sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 42,417 shares — an estimated $398K sold.

HRT Financial first reported a position in AMAG in Q3 2019 and held it in 4 quarters. The position peaked at $398K in Q3 2020. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.

  • HRT Financial reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • HRT Financial sold 42,417 AMAG Pharmaceuticals shares in Q4 2020, an estimated $398K.
  • HRT Financial first reported a position in AMAG Pharmaceuticals in Q3 2019 and held it in 4 quarters.
  • HRT Financial's AMAG Pharmaceuticals position peaked at $398K in Q3 2020.
  • 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.

Based on HRT Financial's 13F filing for Q4 2020, filed 16 Feb 2021.